Crossmark

AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

Published Online: 2019-02-21

Published Print: 2019-12

Authors

Cao, Wei

Li, Jieqing

Hao, Qiongyu

Vadgama, Jaydutt V

Wu, Yong https://orcid.org/0000-0002-1698-0897
Funding

Funding for this research was provided by:

National Institute on Minority Health and Health Disparities (U54MD007598)

National Institutes of Health (U54CA14393)

National Institutes of Health (U56CA101599-01)

National Institutes of Health (UL1TR000124)

National Institutes of Health (SC1CA200517)

Department-of-Defense Breast Cancer Research Program (BC043180)

National Natural Science Foundation of China (81630049)

Changjiang Scholar Program of Chinese Ministry of Education (2017YFC0113302)

China Scholarship Council (201706165022)
License Information

Text and Data Mining valid from 2019-02-21

Version of Record valid from 2019-02-21
More Information

Article History

First Online: 21 February 2019

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current